222 related articles for article (PubMed ID: 21031619)
1. In vitro antiviral activity of lutein against hepatitis B virus.
Pang R; Tao JY; Zhang SL; Zhao L; Yue X; Wang YF; Ye P; Dong JH; Zhu Y; Wu JG
Phytother Res; 2010 Nov; 24(11):1627-30. PubMed ID: 21031619
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
3. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
4. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
7. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro.
Xu J; Wang J; Deng F; Hu Z; Wang H
Antiviral Res; 2008 Jun; 78(3):242-9. PubMed ID: 18313149
[TBL] [Abstract][Full Text] [Related]
8. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
[TBL] [Abstract][Full Text] [Related]
9. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y
Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
[TBL] [Abstract][Full Text] [Related]
10. [Inhibiting effects of the ethanol-soluble extracts from the dried rhizoma of Garcinia oblougififolia on hepatitis B virus in vitro].
Yu Z; Chen W; Zheng Y
Zhong Yao Cai; 1999 Mar; 22(3):142-3. PubMed ID: 12575099
[TBL] [Abstract][Full Text] [Related]
11. In vitro anti-hepatitis B virus effect of Hypericum perforatum L.
Pang R; Tao J; Zhang S; Zhu J; Yue X; Zhao L; Ye P; Zhu Y
J Huazhong Univ Sci Technolog Med Sci; 2010 Feb; 30(1):98-102. PubMed ID: 20155464
[TBL] [Abstract][Full Text] [Related]
12. A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes.
Shin MS; Kang EH; Lee YI
Antiviral Res; 2005 Sep; 67(3):163-8. PubMed ID: 16118024
[TBL] [Abstract][Full Text] [Related]
13. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis B virus activity of α-DDB-DU, a novel nucleoside analogue, in vitro and in vivo.
Zheng LY; Zang LM; Yang QH; Yu WQ; Fang XZ; Zhang YH; Zhao XJ; Wan N; Zhang YT; Wang QD; Chang JB
Eur J Pharmacol; 2013 Feb; 702(1-3):258-63. PubMed ID: 23415746
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HBV effect of targeted antisense RNA against HBV C gene].
Zhang J; Chen F; Zhong S; Tang K; Shi X; Wang M; Peng J
Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):169-70. PubMed ID: 10880169
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik.
Wu LL; Yang XB; Huang ZM; Liu HZ; Wu GX
Acta Pharmacol Sin; 2007 Mar; 28(3):404-9. PubMed ID: 17303004
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents.
Janmanchi D; Tseng YP; Wang KC; Huang RL; Lin CH; Yeh SF
Bioorg Med Chem; 2010 Feb; 18(3):1213-26. PubMed ID: 20061158
[TBL] [Abstract][Full Text] [Related]
19. The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters.
Tseng YP; Kuo YH; Hu CP; Jeng KS; Janmanchi D; Lin CH; Chou CK; Yeh SF
Antiviral Res; 2008 Mar; 77(3):206-14. PubMed ID: 18249449
[TBL] [Abstract][Full Text] [Related]
20. The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs.
Weiss L; Kekulè AS; Jakubowski U; Bürgelt E; Hofschneider PH
Virology; 1996 Feb; 216(1):214-8. PubMed ID: 8614990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
